Alphamab Oncology
HKEX:9966.HK
3.87 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 1,085.988 | 1,069.189 | 803.306 | 185.321 | 1,867.866 | 633.712 | 0.057 |
| Short Term Investments
| 321.248 | 247.858 | 1,128.168 | 1,835.398 | 514.569 | 0 | 0.6 |
| Cash and Short Term Investments
| 1,407.236 | 1,350.377 | 1,985.484 | 2,064.249 | 2,382.435 | 633.712 | 0.657 |
| Net Receivables
| 7.131 | 15.49 | 7.606 | -43.53 | -11.68 | 0 | -0.6 |
| Inventory
| 78.747 | 64.636 | 57.908 | 44.321 | 25.918 | 7.068 | 3.486 |
| Other Current Assets
| 65.416 | 97.357 | 119.561 | 134.188 | 47.795 | 15.323 | 7.072 |
| Total Current Assets
| 1,558.53 | 1,494.53 | 2,116.549 | 2,199.228 | 2,444.468 | 656.103 | 11.215 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 556.841 | 619.743 | 530.523 | 393.021 | 355.956 | 135.091 | 10.582 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 20.691 | 21.185 | 21.68 | 22.175 | 22.669 | 24.73 | 24.73 |
| Goodwill and Intangible Assets
| 20.691 | 21.185 | 21.68 | 22.175 | 22.669 | 24.73 | 24.73 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.051 | -21.185 | -21.68 | -22.175 | 31.49 | 10.969 | 0.05 |
| Total Non-Current Assets
| 578.583 | 619.743 | 530.523 | 393.021 | 410.115 | 170.79 | 35.362 |
| Total Assets
| 2,137.113 | 2,117.531 | 2,705.091 | 2,639.522 | 2,854.583 | 826.893 | 46.577 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 27.163 | 12.127 | 28.481 | 5.277 | 6.853 | 0.766 | 1.728 |
| Short Term Debt
| 80.498 | 190.113 | 463.814 | 198.146 | 41.831 | 10.502 | 2.008 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -1.119 | -190.113 | -463.814 | -198.146 | 0 | 0 | -2.008 |
| Other Current Liabilities
| 160.296 | 372.785 | 608.779 | 324.258 | 151.846 | 71.532 | 8.538 |
| Total Current Liabilities
| 266.838 | 384.912 | 637.26 | 329.535 | 200.53 | 82.8 | 10.266 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 176.582 | 150 | 153.826 | 21.35 | 211.345 | 100.518 | 0 |
| Deferred Revenue Non-Current
| 21.581 | 19.668 | 24.086 | 12.244 | 16.783 | 10 | 10 |
| Deferred Tax Liabilities Non-Current
| -21.581 | 130.332 | 129.74 | 9.106 | 201.25 | -99.25 | 0 |
| Other Non-Current Liabilities
| 21.581 | -150 | -153.826 | -21.35 | -201.25 | 999.853 | 0 |
| Total Non-Current Liabilities
| 198.163 | 150 | 153.826 | 21.35 | 228.128 | 1,011.121 | 10 |
| Total Liabilities
| 465.001 | 559.859 | 834.802 | 366.438 | 428.658 | 1,093.921 | 20.266 |
| Equity: | |||||||
| Preferred Stock
| 0 | 35.853 | 39.841 | 45.454 | 42.049 | 147.373 | 4.175 |
| Common Stock
| 0.013 | 0.013 | 0.013 | 0.013 | 0.012 | 0.007 | 20.4 |
| Retained Earnings
| -2,342.956 | -2,132.363 | -1,806.641 | -1,394.224 | -966.458 | -147.373 | -4.175 |
| Accumulated Other Comprehensive Income/Loss
| 1,672.099 | -35.853 | -39.841 | -45.454 | -42.049 | -8.235 | -1.189 |
| Other Total Stockholders Equity
| 2,342.956 | 3,690.022 | 3,676.917 | 3,667.295 | 3,392.371 | -258.8 | -5.792 |
| Total Shareholders Equity
| 1,672.112 | 1,557.672 | 1,870.289 | 2,273.084 | 2,425.925 | -267.028 | 13.419 |
| Total Equity
| 1,672.112 | 1,557.672 | 1,870.289 | 2,273.084 | 2,425.925 | -267.028 | 26.311 |
| Total Liabilities & Shareholders Equity
| 2,137.113 | 2,117.531 | 2,705.091 | 2,639.522 | 2,854.583 | 826.893 | 46.577 |